$23.61
-0.47-1.95%
Last update: Nov 6, 5:28 PM

The average analyst price target for Rentokil Initial is $32, 38.2% above the current price. Of 8 analysts, 6 rate it Buy and 2 Hold. Targets range from $29 to $35. The latest change came on Jul 7, 2026, when Goldman Sachs upgraded Rentokil Initial from Neutral to Buy.
Price Target Range — 2 Quarters
Analyst Consensus — 8 Analysts
Rating Trend — Last 9 Months